Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 5, No 3 (2009) SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS Abstract  similar documents
E. S. Kropacheva
"... complications is analyzed according to the evidence base medicine approach. Possible hemorrhagic complications ..."
 
Vol 12, No 5 (2016) The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin Abstract  similar documents
I. Yu. Koroleva, I. V. Kolesnichenko, V. P. Nosov, M. V. Zlobin, D. I. Abelevich
"... Aim. To study the effect of rivaroxaban compared with warfarin on the incidence of cardioembolic ..."
 
Vol 10, No 3 (2014) PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD Abstract  similar documents
L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko
"... Adequate primary and secondary prevention of thromboembolic complications is one of the main goals ..."
 
Vol 9, No 3 (2013) ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT Abstract  similar documents
E. L. Dolgova, I. M. Sokolov, Yu. G. Shvarts
"... Data on the problem of thromboembolic complications in non-valvular atrial fibrillation ..."
 
Vol 7, No 1 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS Abstract  similar documents
M. Yu. Gilyarov, V. A. Sulimov
"... fibrillation. Factors of warfarin therapy efficacy, as well as the possibility of new antithrombotic drugs ..."
 
Vol 7, No 2 (2011) PECULIAR PROPERTIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION. IS IT POSSIBLE TO DO THE TREATMENT SAFE? Abstract  similar documents
I. V. Zotova, D. A. Zateyshchikov
"... complications. Possible ways to minimize the hemorrhagic risk in different groups of hypertensive patients who ..."
 
Vol 11, No 3 (2015) ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... , and a reduction of the in-hospital expenses on complications treatment. Switching from warfarin to apixaban ..."
 
Vol 16, No 1 (2020) Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report) Abstract  similar documents
N. T. Vatutin, G. G. Taradin, G. A. Ignatenko, E. S. Gasendich, A. V. Harchenko, I. B. Povaljaeva
"... considering a frequent administration of several drugs having different drug-drug interactions. Warfarin ..."
 
Vol 10, No 2 (2014) SECONDARY PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE CLINICIANS’ VIEWPOINT Abstract  similar documents
E. A. Drozdova
"... assessment of warfarin and dabigatran therapies is given. ..."
 
Vol 15, No 4 (2019) Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
"... results demonstrate a favorable efficiency and safety profile of rivaroxaban in comparison with warfarin ..."
 
Vol 14, No 1 (2018) THE CONTROL OF INTERNATIONAL NORMALISED RATIO IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN IN OUTPATIENT AND HOSPITAL SETTINGS: DATA FROM RECVASA REGISTRIES Abstract  similar documents
M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, T. A. Gomova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, M. A. Bichurina, L. A. Matskevich, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. D. Deev, O. M. Drapkina, s. A. Boytsov
"... in patients with atrial fibrillation (AF) receiving anticoagulant therapy with warfarin. Material and methods ..."
 
Vol 14, No 5 (2018) Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
 
Vol 11, No 2 (2015) ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY Abstract  PDF (Eng)  similar documents
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina
"... %) was revealed in 79%. 8.45% of the vitamin K antagonist treated patients developed hemorrhagic complications. 16 ..."
 
Vol 16, No 1 (2020) Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice Abstract  similar documents
A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko
"... and systemic thromboembolism. For patients that were treated by warfarin international normalization ratio (INR ..."
 
Vol 10, No 3 (2014) COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Rudakova, V. A. Parfenov
"... K antagonists (such as warfarin), antiplatelet therapy (such as acetylsalicylic acid) and novel oral ..."
 
Vol 7, No 4 (2011) LEFT VENTRICULAR CLOT LYSIS DUE TO COMBINED ANTICOAGULANT THERAPY WITH WARFARIN AND FRAXIPARINE IN PATIENT WITH DILATED CARDIOMYOPATHY AND CHRONIC HEART FAILURE. THE CLINICAL CASE Abstract  similar documents
O. V. Uskova, K. O. Sobolev, G. E. Gendlin, A. V. Melekhov
"... anticoagulant therapy with warfarin and fraxiparine in patient with dilated cardiomyopathy, congestive heart ..."
 
Vol 15, No 3 (2019) Features of Thromboembolic and Hemorrhagic Complications in Planned Surgical Interventions in Patients with Atrial Fibrillation Abstract  similar documents
L. N. Uddin, A. V. Egorov, A. A. Sokolova, N. S. Morozova, D. A. Napalkov, V. V. Fomin
"... and hemorrhagic complications in patients with atrial fibrillation (AF) during planned surgical interventions ..."
 
Vol 14, No 1 (2018) NEW APPROACHES TO INDIVIDUALIZED CHOICE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
Ju. P. Skirdenko, N. A. Nikolayev
"... was the low adherence to medical support, which directly related with the frequency of complications ..."
 
Vol 12, No 5 (2016) Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms Abstract  PDF (Eng)  similar documents
Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev
"... compared with patients of warfarin group. Mutations in CYP2C9 gene were detected in 32.9%, VKORC1 – in 68 ..."
 
Vol 15, No 5 (2019) Clinical Case: Atypical Warfarin-induced Skin Necrosis Abstract  similar documents
T. V. Kondratieva, L. V. Popova, S. S. Karachev, A. S. Lishuta, M. Z. Kanevskaya
"... Warfarin-induced skin necrosis (WISN) is a rare complication of antivitamin K therapy, which occurs ..."
 
Vol 6, No 5 (2010) THE INVASIVE DENTAL PROCEDURES IN PATIENTS TREATING WITH WARFARIN: POSSIBILITIES AND PROSPECTS FOR SAFETY Abstract  similar documents
T. V. Kozlova, I. M. Makeyeva, V. Y. Doroshina, S. I. Bokareva
"... in the perioperative continuation or termination of warfarin therapy is shown. Potential of the local hemostatic agents ..."
 
Vol 6, No 4 (2010) ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS Abstract  similar documents
A. Y. Rychkov, N. Y. Khor'kova, A. A. Bliznyakov
"... Appropriate use of warfarin is not in routine clinical practice despite convincing data ..."
 
Vol 12, No 5 (2016) Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation Abstract  similar documents
N. A. Novikova, A. N. Volovchenko
"... stroke. The risk of thromboembolic complications increases significantly when performing for electrical ..."
 
Vol 12, No 5 (2016) Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease Abstract  similar documents
I. S. Daabul, A. A. Sokolova, D. A. Napalkov
"... of the main studies didn't yield or exceeded warfarin concerning balance of efficiency and safety. However ..."
 
Vol 12, No 2 (2016) ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, A. V. Rodionov
"... and safety of apixaban with these of warfarin in patients with atrial fibrillation and a history of ischemic ..."
 
Vol 8, No 4 (2012) WARFARIN IN PATIENTS WITH CARDIOEMBOLIC STROKE Abstract  similar documents
E. N. Dankovtseva, S. L. Arkhipov, D. A. Zateyshchikov
"... Analysis of the current literature data on the use of warfarin in patients with cardioembolic ..."
 
Vol 15, No 4 (2019) Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko
"... complications in atrial fibrillation, including those with concomitant renal pathology, was considered warfarin ..."
 
Vol 13, No 5 (2017) WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT Abstract  similar documents
S. Yu. Martsevich, Y. V. Lukina
"... " of the OAC is warfarin, which has proved effectiveness in all categories of patients with AF. A whole group ..."
 
Vol 7, No 5 (2011) ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, I. S. Yavelov, D. Yu. Belousov, E. V. Afanasieva
"... Aim. To analyze the structure of expenses associated with warfarin dose adjustment ..."
 
Vol 15, No 1 (2019) Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City Abstract  similar documents
A. A. Tuchkov, N. G. Gogolashvili, R. A. Yaskevich
"... with the risk of thromboembolic complications, and also to study the dynamics of the frequency of administration ..."
 
Vol 8, No 3 (2012) RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
M. Yu. Gilyarov
"... -salicylic acid, warfarin). Efficacy and safety of rivaroxaban is considered on the basis of the results ..."
 
Vol 8, No 2 (2012) QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL Abstract  similar documents
E. L. Artanova, L. E. Kon'shina, I. M. Sokolov, Y. G. Shvarts
"... with warfarin after leaving the international clinical trial. Material and Methods. Patients with AF who were ..."
 
Vol 15, No 1 (2019) Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko
"... antagonists (warfarin) or with direct oral anticoagulants. A high risk of thromboembolic complications (CHA2DS ..."
 
Vol 14, No 6 (2018) Anticoagulant Therapy in “Fragile” Elderly Patients: Current State of the Problem Abstract  PDF (Eng)  similar documents
N. M. Vorobyeva, O. N. Tkacheva
"... with warfarin reduced the risk of stroke/systemic embolism and ischemic stroke alone in fragile elderly patients ..."
 
Vol 14, No 5 (2018) Excessive Hypocoagulation in Therapy with Warfarin within Polypharmacy: Using online database Multi-Drug Interaction Checker and Graphic “Time-Effect-Drug Administration” to Eliminate Adverse Drug Event (Case Report) Abstract  similar documents
G. S. Krasnov, I. V. Kazancev
"... . As a result of analysis, it was  described two  drug  interactions led to minor bleeding: warfarin ..."
 
Vol 14, No 4 (2018) Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing Abstract  similar documents
A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik
"... patients, including warfarin (39.5%), direct oral anticoagulants (DOAC) (46.5%) and low-molecular weight ..."
 
Vol 12, No 4 (2016) The use of oral anticoagulants in patients with atrial fibrillation: cohort study data Abstract  similar documents
O. V. Gaisenok, A. S. Leonov
"... . Results. The rate of OAC use was 46.5% (warfarin – 22.4%, NOAC – 20.7%), antiplatelet agents use – 60 ..."
 
Vol 14, No 3 (2018) APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova
"... oral anticoagulants (NOAC) instead of vitamin K antagonists (eg, warfarin), low doses of NOAC, studied ..."
 
Vol 7, No 4 (2011) SPECIAL CONSIDERATIONS REGARDING WARFARIN DOSE TITRATION IN PATIENTS WITH ATRIAL FIBRILLATION DEPENDING ON CLINICAL FACTORS Abstract  similar documents
E. L. Artanova, E. V. Saleeva, I. M. Sokolov, Y. G. Shvarts
"... Aim. To study the relations of clinical characteristics and individual warfarin dose titration ..."
 
Vol 9, No 4 (2013) COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE Abstract  similar documents
L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky
"... Aim. To compare direct medical costs of dabigatran and warfarin therapy in patients with non ..."
 
Vol 10, No 4 (2014) NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
 
Vol 15, No 2 (2019) Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology Abstract  similar documents
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov, G. Yu. Trufanova
"... of three NOAC) in comparison to warfarin reduced the risk of stroke/systemic embolism and ischemic stroke ..."
 
Vol 10, No 2 (2014) ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Maslakov
"... complications (CHA2DS2-VASc≥2) was revealed in 93% patients (n=245), 65% (n=172) of them received warfarin ..."
 
Vol 3, No 2 (2007) VARFARIN DOSE REGIME APPROACHS BASED ON PHARMACOGENETICS TEST RESULTS: REAL POSSIBILITY TO OPTIMIZE THE PHARMACOTHERAPY Abstract  similar documents
D. A. Sychev, I. M. Antonov, S. V. Zagrebin, N. A. Gasanov, V. G. Kukes
"... Indirect anticoagulants effectively prevent thromboembolic complications in patients with high ..."
 
Vol 8, No 1 (2012) PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov
"... the cost-effectiveness of dabigatran etexilate versus warfarin prescribed in “real-world” settings from ..."
 
Vol 15, No 5 (2019) Prediction of the Possibility of Hemorrhagic Syndrome during Combined Antiplatelet Therapy According to the Krasnodar Region Registry Abstract  similar documents
Z. G. Tatarintseva, E. D. Kosmacheva, S. V. Kruchinova, V. A. Akinshina, A. A. Khalafyan
"... complications. However, this combination is fraught with the development of hemorrhagic syndrome. Aim ..."
 
Vol 12, No 4 (2016) Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true Abstract  similar documents
Yu. A. Bunin, S. V. Miklishanskaya
"... of them oral anticoagulants were used mainly from the group of vitamin K antagonists, most often warfarin ..."
 
Vol 15, No 4 (2019) Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen Abstract  similar documents
A. I. Kochetkov, O. D. Ostroumova
"... of evidence showing their high safety and efficacy, which in some cases exceed those of warfarin, and also ..."
 
Vol 13, No 6 (2017) PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS Abstract  similar documents
A. А. Sokolova, A. V. Zhilenko, I. L. Tsarev,, D. A. Napalkov, V. V. Fomin
"... when choosing a dose of the drug. Markers of hemorrhagic complications development were not determined ..."
 
Vol 11, No 1 (2015) PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... (warfarin), antiplatelet therapy (acetylsalicylic acid) and novel oral anticoagulants such as apixaban ..."
 
Vol 2, No 3 (2006) ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
"... , warfarin, ticlopidine and clopidogrel are discussed. Study data on new antiplatelet drugs are given ..."
 
Vol 9, No 5 (2013) APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA Abstract  similar documents
D. A. Sychev, R. E. Kazakov, V. A. Otdelenov, A. B. Prokofiev
"... response to oral anticoagulants is considered. Possible tactics of warfarin dosing and new oral ..."
 
Vol 10, No 4 (2014) MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
E. A. Belikov, K. V. Davtyan, O. N. Tkacheva
"... Prevention of thromboembolic complications in patients with atrial fibrillation during catheter ..."
 
Vol 13, No 2 (2017) APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... tools used to assess risks of thromboembolic and hemorrhagic complications and general approaches ..."
 
Vol 9, No 4 (2013) COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS Abstract  similar documents
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova
 
Vol 14, No 2 (2018) NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov
"... and systemic thromboembolic (STE) complications as warfarin, although DOACs were associated with less risk ..."
 
Vol 8, No 5 (2012) RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE Abstract  similar documents
I. V. Grajfer, L. E. Kuvshinova, P. V. Dolotovskaya, O. V. Reshet'ko, N. V. Furman
"... fibrillation (AF) with the risk level of thromboembolic complications (TEC), calculated with the СHADS2 and CHA ..."
 
Vol 15, No 4 (2019) The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) Abstract  similar documents
M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov
"... (1335 from 3169 patients; age 69.1±10.4 years, 43% men), including warfarin (817 patients; 26%) and non ..."
 
Vol 14, No 3 (2018) THROMBOSIS OF LEFT ATRIAL APPENDAGE DURING THERAPY WITH DIRECT ORAL ANTICOAGULANT. CLINICAL CASE Abstract  similar documents
I. S. Daaboul, S. Yu. Koroleva, A. A. Kudrjavtseva, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
"... of thromboembolic complications. In connection with the categorical refusal of the patient from warfarin ..."
 
Vol 15, No 5 (2019) Rivaroxaban-Associated Hepatotoxicity: a Clinical Case and Literature Review Abstract  similar documents
B. A. Tatarsky, N. V. Kazennova, D. A. Napalkov
"... .g. warfarin), have a predictable manifestation of the anticoagulant effect and the possibility of using ..."
 
Vol 14, No 6 (2018) Antithrombotic Therapy in Patients with Atrial Fibrillation after Myocardial Infarction: Clinical Guidelines and Actual Practice Abstract  PDF (Eng)  similar documents
K. G. Pereverzeva, S. S. Yakushin, A. E. Pripadcheva, N. P. Agaltsova
"... .9%) – pernanent. Results. While assessing the risk of thromboembolic complications on the CHA2DS2-VASc scale ..."
 
Vol 10, No 4 (2014) FEATURES OF THE CARDIOVERSION IN ATRIAL FLUTTER AND FIBRILLATION IN ERA OF NEW ANTICOAGULANTS: PRACTICAL CARDIOLOGIST VIEW Abstract  similar documents
S. A. Zenin, A. V. Fedoseenko, O. V. Kononenko, O. V. Pyataeva
"... base and analysis of complications of different anticoagulants use for safety of sinus rhythm ..."
 
Vol 11, No 5 (2015) Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism Abstract  similar documents
A. V. Rudakova
"... of venous thromboembolism (VTE) compared with low molecular weight heparin (LMWH)/warfarin and other new ..."
 
Vol 8, No 4 (2012) THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY Abstract  similar documents
M. Yu. Gilyarov
"... . Along with traditional drugs (acetylsalicylic acid, warfarin) rivaroxaban is specially considered ..."
 
Vol 13, No 1 (2017) ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY Abstract  similar documents
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... anticoagulants. Combined therapy of antiplatelet drugs with warfarin or new oral anticoagulants results ..."
 
Vol 10, No 6 (2014) THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY Abstract  similar documents
A. A. Rumyantsev, I. A. Pokataev, T. V. Kozlov, N. A. Rumyantsev
"... for anticoagulant prevention. Besides, heparin and warfarin use for VTE prevention in cancer is accompanied by some ..."
 
Vol 7, No 6 (2011) CORONARY EMBOLISM WITH FRAGMENTED THROMBUS FROM THE LEFT VENTRICLE IN PATIENT WITH POSTINFARCTION ANEURYSM Abstract  similar documents
Yu. F. Salakhova, S. V. Gar'kina, T. V. Kislukhin, D. V. Duplyakov, V. S. Ivanov, E. R. Perunova, E. I. Bazhenova, S. E. Burnazyan, S. M. Khokhlunov
"... The thrombus formation in the left ventricle (LV) cavity is a frequent complication of myocardial ..."
 
Vol 13, No 5 (2017) ADHERENCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION – THE WAY TO SOLVE THE PROBLEM OF EFFICACY AND SAFETY OF TREATMENT Abstract  similar documents
S. G. Kanorskii
"... of anticoagulant therapy include vitamin K antagonists, such as warfarin, whose  benefits are long established ..."
 
Vol 7, No 6 (2011) DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER Abstract  similar documents
I. S. Yavelov
"... Application of dabigatran etexilate for prevention of cardioembolic complications in nonvalvular ..."
 
Vol 8, No 6 (2012) HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
S. V. Moiseev
"... clinical trial dabigatran 150 mg b.i.d was more effective than warfarin in prevention of ischemic stroke ..."
 
Vol 9, No 4 (2013) URAPIDIL: MODERN MEDICINE FOR THE TREATMENT OF HYPERTENSIVE CRISES Abstract  similar documents
A. V. Melekhov, Yu. I. Ostrovskaya
"... by a hemorrhagic stroke. Material and methods. Patients (n=86) aged 46-87 years (42 men and 44 women) who were ..."
 
Vol 12, No 2 (2016) THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN CLINICAL PRACTICE Abstract  similar documents
S. V. Moiseev
"... (dabigatran), today are increasingly replacing warfarin and other indirect anticoagulants in preventing stroke ..."
 
Vol 9, No 5 (2013) PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
E. D. Kosmacheva, S. G. Kanorskiy, A. A. Kastanayan, N. V. Haylo, D. B. Goltyapin, E. A. Lipnitskaya, M. E. Statsenko
"... Disadvantages of vitamin K antagonist warfarin and the benefits of new anticoagulants, including ..."
 
Vol 14, No 2 (2018) WHAT DO PATIENTS WITH ATRIAL FIBRILLATION KNOW ABOUT STROKE AND SYSTEMIC EMBOLISM PREVENTION? DATA OF THE PRIMA-TERRA REGISTRY Abstract  similar documents
R. М. Linchak, O. G. Kompaniyets, A. M. Nedbaykin
"... % of patients were informed of possible AF complications, of which less than a third – about the risk of stroke ..."
 
Vol 14, No 3 (2018) ROLE OF SYNTAX SCORE SCALE IN THE STRATIFICATION OF THE NOSOCOMIAL RISK OF CARDIOVASCULAR COMPLICATIONS AND LETHALITY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
D. B. Nemik, G. V. Matyushin, S. A. Ustyugov
"... . The frequency of hemorrhagic complications did not depend on the severity of the coronary bed lesion ..."
 
Vol 10, No 6 (2014) THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER Abstract  similar documents
S. Y. Martsevich, A. R. Navasardyan, N. P. Kutishenko, A. V. Zakharova, V. P. Voronina, N. A. Dmitrieva, L. Yu. Lrozdova, A. V. Zagrebelnyy, O. V. Lerman, Yu. V. Lukina, G. V. Martynova, A. A. Nikulina, G. S. Ryazanova, A. Yu. Suvorov, S. N. Tolpygina
"... refusal were satisfactory with warfarin (32.6%), the high price of these drugs (23.9%), the description ..."
 
Vol 14, No 5 (2018) Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF Study Abstract  similar documents
I. L. Polshakova, S. V. Povetkin
"... complications. In most patients, anti-platelet drugs were used as antithrombotic therapy, although ..."
 
Vol 15, No 6 (2019) Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Kemerovo) Abstract  similar documents
D. Yu. Sedykh, V. V. Kashtalap, R. M. Velieva, O. L. Barbarash
"... and hemorrhagic events in patients with ST-elevated myocardial infarction (MI) during a year of follow-up, taking ..."
 
Vol 9, No 2 (2013) ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS Abstract  similar documents
O. V. Shatalova, O. N. Smuseva, A. S. Maslakov
"... .2% (4/18), and antiplatelet drugs 11.1% (2/18). Conclusion. Warfarin was more often cause of ADR during ..."
 
Vol 9, No 1 (2013) EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS Abstract  similar documents
E. V. Akhmedova, Z. A. Toguzova, M. N. Mamedov
"... causes of death in patients with DM are macrovascular complications. Intensive hypoglycemic therapy ..."
 
Vol 10, No 6 (2014) PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION Abstract  similar documents
N. V. Mikheeva, O. V. Reshetko, N. V. Furman
"... .12.2011. Results. Acetylsalicylic acid was prescribed to 66.7% of patients, warfarin – 3.9%. At that target level ..."
 
Vol 14, No 4 (2018) Possibilities of Using Rivaroxaban in Elderly Patients with Atrial Fibrillation: Data from Randomized Studies and Real Clinical Practice Abstract  similar documents
N. M. Vorobyeva, O. N. kacheva
"... антикоагулянтов в реальной клинической практике и вопросы приверженности пациентов к антикоагулянтной терапии ..."
 
Vol 14, No 4 (2018) Differences in the Incidence of Major Risk Factors in Patients with Ischemic or Hemorrhagic Stroke in the Siberian Population Abstract  similar documents
S. Yu. Nikulina, A. A. Chernova, D. A. Nikulin, V. A. Shulman, S. V. Prokopenko, I. M. Platunova, O. V. Marilovceva, I. I. Lebedeva, A. A. Semenchukov, D. A. Yakovleva, V. N. Maksimov, A. V. Kuskaeva
"... the frequency of the main RF in patients with ischemic and hemorrhagic stroke in the urban population ..."
 
Vol 9, No 4 (2013) STATINS IN PREVENTION OF ISCHEMIC STROKE Abstract  similar documents
A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk
 
Vol 9, No 4 (2013) NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY Abstract  similar documents
A. V. Rudenko, B. A. Rudenko
 
Vol 5, No 4 (2009) PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
 
Vol 10, No 5 (2014) STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE Abstract  similar documents
V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev
"... modification of cardiovascular complications in the perioperative period. Particular attention has recently ..."
 
Vol 15, No 5 (2019) Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, S. P. Korchagina, T. M. Ostroumova, M. S. Chernyaeva, A. A. Kirichenko
"... антикоагулянтной терапии как метода профилактики развития инсульта, который может являться фактором ..."
 
Vol 13, No 2 (2017) ORAL ANTICOAGULANTS IN AMBULATORY AND IN-HOSPITAL TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION ASSOCIATED WITH HYPERTENSION, ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE: DATA FROM HOSPITAL REGISTRY RECVASA-CLINIC Abstract  PDF (Eng)  similar documents
E. V. Stepina, M. M. Loukianov, M. A. Bichurina, E. N. Belova, E. V. Kudryashov, Ju. V. Uzkov, S. A. Boytsov
"... Цель. Изучить частоту назначения оральных антикоагулянтов (ОАК), преемственность антикоагулянтной ..."
 
Vol 9, No 2 (2013) LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER CEREBRAL STROKE OR TRANSIENT ISCHEMIC ATTACK (LIS-2). DESIGN AND MEDICAL TREATMENT ESTIMATION Abstract  PDF (Eng)  similar documents
S. A. Boytsov, S. Yu. Martsevich, M. L. Ginzburg, N. P. Kutishenko, L. Yu. Drozdova, A. V. Akimova, A. Yu. Suvorov, M. M. Loukianov, N. A. Dmitrieva, O. V. Lerman, N. Yu. Zhuravskaya, E. V. Daniels, A. V. Fokina, V. N. Yudaev, V. P. Smirnov, A. M. Kalinina, S. V. Kotov, L. V. Stahovskaya
"... , 4 (1%) – warfarin. Statins intake was recommended to 3 (1%) patients. Conclusion. We revealed low ..."
 
Vol 11, No 2 (2015) THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS Abstract  similar documents
E. EL. Trisvetova
"... Despite progress in reducing the risk of hypertension (HT) complications, control of blood ..."
 
Vol 1, No 3 (2005) TRANSIENT ISCHEMIC ATTACK AS AN ARTERIAL HYPERTENSION COMPLICATION Abstract  similar documents
G. N. Gorochovskaya, A. P. Kondrachin, A. I. Martinov
 
Vol 6, No 5 (2010) EFFECT OF BETA-BLOCKERS ON BLOOD PRESSURE, PERIOPERATIVE COMPLICATIONS AND HOSPITAL STAY DURATION IN PATIENTS WITH INTERMEDIATE RISK OF CARDIOVASCULAR COMPLICATIONS AFTER ROUTINE CHOLECYSTECTOMY: AN OPEN COMPARATIVE RANDOMIZED STUDY Abstract  similar documents
O. L. Barbarash, R. V. Repnikova, T. V. Shoforus, O. I. Golofaeva
"... year worldwide, and cardiovascular complications happen in 500 000 - 900 000 patients. Aim ..."
 
Vol 9, No 4 (2013) USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? Abstract  similar documents
V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev
"... of risk modification of cardiovascular complications in the perioperative period. Therefore, special ..."
 
Vol 2, No 3 (2006) APPLICATION OF CALCIUM ANTAGONISTS IN PREVENTION OF CARDIOVASCULAR COMPLICATIONS DURING CARDIAC SURGERY Abstract  similar documents
S. V. Nedogoda
"... perioperative complications during aortocoronary bypass procedure and operations on heart valves are analyzed ..."
 
Vol 14, No 4 (2018) Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases Abstract  similar documents
O. Yu. Chizhova, L. N. Belousova, I. G. Bakulin
"... hemorrhagic complications, especially gastrointestinal bleeding, remain unresolved. Currently ..."
 
Vol 13, No 1 (2017) RESULTS OF HOSPITAL USE OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE IN PATIENTS WITH ST-ELEVATED MYOCARDIAL INFARCTION Abstract  similar documents
V. B. Kostogryz
"... verification of the degree of blood flow in the infarct-related coronary  artery. Hemorrhagic complications ..."
 
Vol 6, No 5 (2010) LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS? Abstract  similar documents
I. V. Zhirov
"... complications of the treatment are discussed. ..."
 
Vol 5, No 6 (2009) ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS Abstract  similar documents
N. A. Dmitrieva, S. N. Tolpygina
 
Vol 13, No 1 (2017) ENDOVASCULAR TREATMENT OF CAROTID ATHEROSCLEROSIS: CONCERNS AND PERSPECTIVES Abstract  similar documents
T. V. Tvorogova, E. S. Bulgakova, F. B. Shukurov, B. A. Rudenko, O. M. Drapkina, A. S. Shanoyan
"... , is also wide-spread but it is associated with more periprocedural complications. Knowledge of risk factors ..."
 
1 - 100 of 278 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)